Summary
Overview
Work History
Education
Skills
Timeline
background-images

SAMUEL C. LUTTRELL

Knoxville,USA

Summary

Dynamic sales professional with a proven track record in the pharmaceutical industry, consistently achieving top 10 national rankings for sales since 2000. Expertise includes a diverse range of products, such as treatments for prostate, lung, and breast cancer, along with gastrointestinal, cardiovascular, and osteoporosis medications. Strong collaborative relationships with physicians, office managers, and billing staff facilitate effective communication regarding product J Codes and Medicare reimbursement processes. A history of exceeding sales goals and assuming district leadership roles underscores a commitment to driving results and enhancing operational efficiency.

Overview

39
39
years of professional experience

Work History

Senior Oncology / Hematology Specialist

Incyte
02.2017 - Current

Promote Jakafi to medical oncologists in East Tennessee, Western North Carolina and SW Virginia.

National ranking 9 of 75 in 2022

National ranking 16 of 79 2021

2022 Mighty Oak Club (Chairman's Circle) winner

2024 Sue Carnes award recipient

Senior Oncology Sales Specialist

MEDIVATION
06.2012 - 02.2017
  • Introduce Xtandi to Medical Oncologists in East Tennessee, Western North Carolina.
  • Ranked 21 out of 60 nationally in 2012.
  • Ranked 7 out of 60 nationally in 2013.
  • Ranked 1 out of 90 nationally In 2014 Xtandi Market Share.
  • Area representative to the field input team 2015 and 2016.
  • Training mentor for new hires 2016.

Oncology Sales Specialist

ARCHIMEDES PHARMA
09.2011 - 05.2012
  • Educate Medical oncologists and Radiation oncologists in East Tennessee about break thru cancer pain and Introduce Lazanda (fentanyl nasal spray).
  • Ranked second regionally in sales 1st quarter 2012.
  • Selected to Vice-Presidents advisory council.

Senior Biopharmaceutical Representative (Bone Health Business Unit)

AMGEN
07.2009 - 08.2011
  • Educate Area physicians regarding recently discovered metabolic pathway responsible for osteoporosis, introduce Amgen to primary care audience and profile accounts for potential to employ a buy and bill model for Prolia.
  • Gained formulary approval and established patient flow procedures for administration at 4 area hospitals.
  • Third place in fast start sales contest in the district for July and November 2010.

Oncology Sales Representative

ASTRAZENECA LP
01.2003 - 07.2009
  • Selected for a specialty contract sales position with Abraxis Bioscience in 2006 selling Abraxane (infused chemotherapy for metastatic breast cancer) and Faslodex (hormone injection for metastatic breast cancer).
  • Increased sales and market share with 60 oncologists in a territory covering all of East Tennessee and parts of Western North Carolina and Southwest Virginia.
  • Exceeded overall 2007 sales goals resulting in a #15 national sales ranking for the year.
  • Increased national sales ranking from #25 for the second trimester of 2006 up to #9 in the third trimester and finished 2006 with a #10 ranking at 119.8% quota.
  • Generated a 35% increase in Abraxane sales from the second trimester to the third trimester of 2006.
  • Selected as a national representative for the 2007-2008 AstraZeneca Voice Team.
  • Chosen for Breast Cancer Preceptorship in June 2007 at M.D. Anderson Cancer Center based on performance.
  • Selected as specialty care mentor for employees identified for career advancement 2007.

Oncology Sales Representative

ASTRAZENECA LP
01.2004 - 01.2006
  • Established a successful record of sales performance in two different oncology divisions during this time that included the direct sale of products to physician clinics for the treatment of prostate cancer (2005-2006) and previous territory responsibility selling products for the treatment of lung and breast cancer from (2004-2005).
  • Increased sales and market share of Zoladex (injectable treatment for metastatic prostate cancer) and Casodex (oral treatment for metastatic prostate cancer) to oncologists and urologists throughout East Tennessee.
  • Turned around one of the lowest ranked territories in the U.S. in 2005 by implementing a targeted sales approach that focused on top prescribers and increased the territory rank for Zoladex to #5 nationally with a 170% payout in the first trimester of 2006.
  • Exceeded sales objective in 2004 with Iressa at 128% to plan (company promotion ended during 4th quarter) and Arimidex at 109% to plan (achieved #6 national market share ranking out of 108 territories; resulted in Arimidex being the top prescribed oral breast cancer treatment in the territory).
  • Promoted into the oncology sales division selling Iressa (oral treatment for lung cancer) and Arimidex (oral treatment for breast cancer) to oncologists in East Tennessee.

Pharmaceutical Sales Representative

ASTRAZENECA LP
08.2000 - 01.2003
  • Initially hired into a primary care sales position and earned recognition for exceeding sales goals on a consistent basis for Toprol XL, Zestril, Prilosec, Crestor and Nexium.
  • District Representative for Pharmaceutical Representative of the Year for 2003 based on overall performance.
  • Implemented successful territory launch of Nexium and achieved #1 sales ranking after one year.
  • Selected as a Crestor Training Champion to train district for upcoming product launch in 2003.
  • Chosen as Field Ride Champion to evaluate potential new candidates 2003.
  • Nashville Business Center Leaders Club Award, May 2002.

Account Representative

ACCESS AMERICA, INC.
04.1999 - 08.2000
  • Developed a strong base of business-to-business sales, cold calling, and presentation experience selling telecommunication services to key decision-makers in a highly competitive industry.
  • Recognized for acquisition of numerous high value accounts possessing extensive data and voice communications networks.
  • Top revenue producer for 1999 and leading revenue producer at time of departure in 2000.
  • Experience contracting with accounts for telecommunications services.

Manager

RUBY TUESDAY, INC.
08.1986 - 04.1999
  • Directed all aspects of business operations including staffing, payroll, inventory and maintenance.
  • Increased sales and profitability for a restaurant with $2.0+ million in annual revenues; managed, trained and motivated 60 employees to exceed customer service expectations.
  • Multiple awards and recognition for exceeding sales and profitability targets.
  • Led the Nation in existing unit sales volume increase year ending 1990 versus 1989 (45 restaurants in division).
  • Opened five new company owned restaurants throughout Southeast.
  • Instituted system wide training program adopted by 45 units to increase team member awareness, improve professionalism and enhance guest relations.

Education

B.S. - Business Administration (Major: Marketing)

THE UNIVERSITY OF TENNESSEE
Knoxville, TN

Skills

  • Customer relations
  • Expert problem solving
  • Analytical thinking
  • Task prioritization
  • Excellent communication
  • Relationship building

Timeline

Senior Oncology / Hematology Specialist

Incyte
02.2017 - Current

Senior Oncology Sales Specialist

MEDIVATION
06.2012 - 02.2017

Oncology Sales Specialist

ARCHIMEDES PHARMA
09.2011 - 05.2012

Senior Biopharmaceutical Representative (Bone Health Business Unit)

AMGEN
07.2009 - 08.2011

Oncology Sales Representative

ASTRAZENECA LP
01.2004 - 01.2006

Oncology Sales Representative

ASTRAZENECA LP
01.2003 - 07.2009

Pharmaceutical Sales Representative

ASTRAZENECA LP
08.2000 - 01.2003

Account Representative

ACCESS AMERICA, INC.
04.1999 - 08.2000

Manager

RUBY TUESDAY, INC.
08.1986 - 04.1999

B.S. - Business Administration (Major: Marketing)

THE UNIVERSITY OF TENNESSEE
SAMUEL C. LUTTRELL